Wilson hastalığı bulunan bir hastada D-penisilamin tedavisi sonucu ortaya çıkan jeneralize miyastenia gravis

Cilt: 52 Sayı: 4 1 Aralık 2013
  • Yiğiter R
  • Elçi M A
  • Kçalı A
  • Altunışık E
  • Demir F
  • Neyal M
PDF İndir
EN TR

Generalized myasthenia gravis following use of D-penicillamine in a patient with Wilson's disease

Abstract

Wilson's disease is an autosomal recessive disease seen in later childhood or young adulthood which is caused by an accumulation of copper in tissues which leads to hepatic, neurological, psychiatric symptoms or a combination of these. A copper chelator agent called D-penicillamine, which is being widely used with other drugs for Wilson's disease, increases copper excretion in urine. Myasthenia gravis is an autoimmune disorder of the neuromuscular junction causing muscle weakness and fatigue. It is known that some drugs such as D-penicillamine can effect the neuromuscular junction and worsen the clinical results of patients. D-penicillamine was given to an 18-year-old female patient with Wilson's disease. The patient was admitted to our clinic with complaints of generalized weakness for three months and after the physical examination and laboratory findings we diagnosed her as having myasthenia gravis secondary to drugs. We have found it significant to present the case that some medicines used in clinical diseases may cause another clinical case. And if an unexpected clinical process develops, the medicines in use may need to be reconsidered.

Keywords

Ayrıntılar

Birincil Dil

Türkçe

Konular

-

Bölüm

-

Yazarlar

Yiğiter R

Elçi M A

Kçalı A

Altunışık E

Demir F

Neyal M

Yayımlanma Tarihi

1 Aralık 2013

Gönderilme Tarihi

1 Aralık 2013

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2013 Cilt: 52 Sayı: 4

Kaynak Göster

Vancouver
1.Yiğiter R, Elçi M A, Kçalı A, Altunışık E, Demir F, Neyal M. Wilson hastalığı bulunan bir hastada D-penisilamin tedavisi sonucu ortaya çıkan jeneralize miyastenia gravis. ETD [Internet]. 01 Aralık 2013;52(4):217-9. Erişim adresi: https://izlik.org/JA68BS22CS

Ege Tıp Dergisi, makalelerin Atıf-Gayri Ticari-Aynı Lisansla Paylaş 4.0 Uluslararası (CC BY-NC-SA 4.0) lisansına uygun bir şekilde paylaşılmasına izin verir.